SAN RAMON, Calif., April 21, 2022 (GLOBE NEWSWIRE) -- CooperCompanies (NYSE: COO) today announced that Cooper and Cook Medical have each received a request for additional information (“second request”) from the U.S. Federal Trade Commission (FTC) in connection with Cooper’s pending acquisition of

EssilorLuxottica and CooperCompanies initiative accelerates commercialization of innovative myopia management technologies CHARENTON-LE-PONT, France and SAN RAMON, Calif., March 17, 2022 (GLOBE NEWSWIRE) -- EssilorLuxottica and CooperCompanies are pleased to announce the finalization of their joint

SAN RAMON, Calif., March 03, 2022 (GLOBE NEWSWIRE) -- CooperCompanies (NYSE: COO) today announced financial results for its first quarter of fiscal year 2022, which ended January 31, 2022. Revenue increased 16% year-over-year to $787.2 million. CooperVision (CVI) revenue up 11% to $561.5 million,

SAN RAMON, Calif., Feb. 17, 2022 (GLOBE NEWSWIRE) -- CooperCompanies (NYSE: COO), will present at Oppenheimer’s 32 nd Annual Healthcare Conference on Wednesday, March 16, 2022. Brian Andrews, Executive Vice President, Chief Financial Officer & Treasurer, will represent the Company in a virtual

Acquisition will enhance CooperSurgical’s international fertility footprint and medical device portfolio SAN RAMON, Calif., Feb. 07, 2022 (GLOBE NEWSWIRE) -- CooperCompanies (NYSE: COO) today announced it has signed a binding letter of intent to acquire Cook Medical’s Reproductive Health business,

SAN RAMON, Calif., Jan. 27, 2022 (GLOBE NEWSWIRE) -- CooperCompanies (NYSE: COO) today announced it will release first quarter 2022 financial results on Thursday, March 3, 2022, at 4:15 PM ET. Following the release, the Company will host a conference call at 5:00 PM ET to discuss the results and

SAN RAMON, Calif., Jan. 06, 2022 (GLOBE NEWSWIRE) -- CooperCompanies (NYSE: COO), will present at the J.P. Morgan Healthcare Conference on Tuesday, January 11, 2022. Al White, President and CEO, will represent the Company in a virtual session scheduled to begin at 2:15 PM ET.

SAN RAMON, Calif., Dec. 17, 2021 (GLOBE NEWSWIRE) -- CooperCompanies (NYSE: COO) today announced it has completed the previously announced definitive purchase agreement to acquire Generate Life Sciences, a leading provider of donor egg and sperm for fertility treatments, fertility cryopreservation

SAN RAMON, Calif., Dec. 15, 2021 (GLOBE NEWSWIRE) -- CooperCompanies (NYSE: COO) today announced that it will hold its next annual meeting of stockholders on Wednesday, March 16, 2022. Stockholders of record as of the close of business on January 20, 2022, will be eligible to vote on matters

SAN RAMON, Calif., Dec. 08, 2021 (GLOBE NEWSWIRE) -- CooperCompanies (NYSE: COO) today announced that consistent with the plan approved by its board of directors to pay annual dividends, the Company declared a semi-annual dividend of 3 cents per share, payable on February 9, 2022, to stockholders